HIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences.
about
Week 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patientsPreexposure prophylaxis-selected drug resistance decays rapidly after drug cessationEnhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.
P2860
HIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
HIV reverse-transcriptase drug ...... ty than in envelope sequences.
@en
HIV reverse-transcriptase drug ...... ty than in envelope sequences.
@nl
type
label
HIV reverse-transcriptase drug ...... ty than in envelope sequences.
@en
HIV reverse-transcriptase drug ...... ty than in envelope sequences.
@nl
prefLabel
HIV reverse-transcriptase drug ...... ty than in envelope sequences.
@en
HIV reverse-transcriptase drug ...... ty than in envelope sequences.
@nl
P2093
P2860
P356
P1476
HIV reverse-transcriptase drug ...... ty than in envelope sequences.
@en
P2093
Jeffrey A Johnson
Jin-fen Li
Jonathan T Lipscomb
S Michele Owen
Silvina Masciotra
P2860
P304
P356
10.1093/INFDIS/JIU333
P407
P577
2014-06-12T00:00:00Z